Dr. Thomas Dayspring

Clinical lipidologist

Lipids • cholesterol and cardiovascular risk

1Episode

109 minAnalysed

1Topic

Last reviewed: Jul 23, 2026·Credential: MD, FACP; clinical lipidologist·First indexed: Jul 23, 2026

About the expert

Focus: Lipids, ApoB, Cardiovascular risk

A clinical lipidologist widely known for teaching how cholesterol and lipoproteins drive heart disease. He focuses on particle-based measures such as ApoB rather than standard cholesterol numbers. His views align with mainstream cardiology and prevention guidelines.

Why this matters

He reads heart risk through cholesterol particles, arguing that ApoB counts what drives plaque better than a standard cholesterol number. His framing is mainstream and evidence-based; the main debate he joins is about treating earlier, not whether lowering these particles helps.

Filter by species:

Topics covered

Cholesterol & Lipid Markers (Human)

Episodes with Dr. Thomas Dayspring

Lowering ApoB and cholesterol: which therapies cut heart risk

Heart disease from narrowing arteries usually builds up gradually over decades, as cholesterol-carrying particles lodge in the artery wall and form fatty plaques. A blood marker called ApoB counts these particles directly, and it can flag risk a standard cholesterol test misses. Several proven medicines lower these particles in different ways. This discussion covers how they work, how well they prevent heart attacks and strokes, and why starting earlier may matter.

109 minHuman

Explore episode →